Randomized, Controlled Dose‐Optimization Studies of Dihydroartemisinin‐Piperaquine for the Treatment of Uncomplicated Multidrug‐Resistant Falciparum Malaria in Thailand-Reference-Cited by-同舟云学术

Randomized, Controlled Dose‐Optimization Studies of Dihydroartemisinin‐Piperaquine for the Treatment of Uncomplicated Multidrug‐Resistant Falciparum Malaria in Thailand

Published:2004-11-15 Issue:10 Volume:190 Page:1773-1782
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Ashley Elizabeth A.,Krudsood Srivicha,Phaiphun Lucy,Srivilairit Siripan,McGready Rose,Leowattana Wattana,Hutagalung Robert,Wilairatana Polrat,Brockman Alan,Looareesuwan Sornchai,Nosten François,White Nicholas J.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/190/10/1773/6464698/190-10-1773.pdf

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput LC-MS/MS assay for piperaquine from dried blood spots: Improving malaria treatment in resource-limited settings;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-01

2. Artesunate-mefloquine therapy for uncomplicated Plasmodium falciparum malaria: an updated systematic review and meta-analysis of efficacy and safety;Transactions of the Royal Society of Tropical Medicine and Hygiene;2023-09-29

3. Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data;BMC Medicine;2022-03-07

4. Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate;Cancer Genomics - Proteomics;2022

5. Metabolism is not a Major Contributor to the Toxicity of Piperaquine, a Long-acting Antimalarial Agent in Artemisinin-based Combination Therapy;Current Drug Metabolism;2021-12-15